logo

For the Inventor, By the Inventor

Villers-Agron-Aiguizy, France

Suzette L Beguin

This inventor holds 2 USPTO granted patents. Top assignee: Synapse B.v.. Active years: 2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Suzette L Beguin. Retrieved from https://idiyas.com/inventor/suzette-l-beguin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2

% Patents Active = 100.0

Average Co-Inventor Count = 5.5

ph-index = 1

Forward Citations = 4(Granted Patents)


Location History:

  • Villers-Agron, FR (2014)
  • Villers-Agron-Aiguizy, FR (2014)

Company Filing History:

goldMedal2 out of 6 
 
Synapse B.v.
 patents

Years Active: 2014

Loading Chart...
2 patents (USPTO):Explore Patents
1. 8916356 - Measuring thrombin activity in whole blood (2014-12-23),
2. 8802386 - Diagnostic test for determining the concentration of transient proteolytic activity in composite biological media (2014-08-12),

Title: The Innovative Contributions of Suzette L Beguin

Introduction

Suzette L Beguin is a notable inventor based in Villers-Agron-Aiguizy, France. She has made significant contributions to the field of medical diagnostics, particularly in the measurement of thrombin activity in blood samples. With a total of 2 patents to her name, her work has the potential to impact both human and animal health.

Latest Patents

One of her latest patents is focused on a method for in vitro determining thrombin activity in a blood sample. This invention involves contacting a layer of the sample with a fluorogenic substrate of thrombin, allowing thrombin to generate, and measuring the fluorescence emitted from the surface of the layer. This method provides a precise way to assess thrombin activity, which is crucial for various medical diagnoses.

Another significant patent by Beguin is a diagnostic test for determining the concentration of transient proteolytic activity in composite biological media. This method allows for real-time monitoring of thrombin activity in blood or plasma samples. By comparing the activity measured in clotting blood with a standard preparation, the exact molar amount of thrombin present can be determined. This innovation is particularly useful for diagnosing hyper- and hypo-coaguable states in both humans and animals.

Career Highlights

Suzette L Beguin is currently associated with Synapse B.V., where she continues to develop her innovative ideas. Her work is characterized by a strong focus on improving diagnostic methods in the medical field.

Collaborations

Throughout her career, she has collaborated with notable professionals such as Robert Wagenvoord and Hendrik Coenraad Hemker. These collaborations have likely contributed to the advancement of her research and the successful development of her patents.

Conclusion

Suzette L Beguin's contributions to the field of thrombin activity measurement highlight her innovative spirit and dedication to improving medical diagnostics. Her patents represent significant advancements that could enhance the understanding and treatment of coagulation disorders.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…